Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
931.15
7.50 (0.81%) Natco Pharma informs about press release
Date: 04-02-2023Natco Pharma has informed that it enclosed press release titled ‘USFDA completes inspection of Natco's Vizag formulation facility’.
The above information is a part of company’s filings submitted to BSE.